Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125383352 | 12538335 | 2 | F | 20160607 | 20160713 | 20160707 | 20160715 | EXP | IT-GILEAD-2016-0222161 | GILEAD | 67.00 | YR | E | F | Y | 0.00000 | 20160715 | MD | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125383352 | 12538335 | 1 | PS | HARVONI | LEDIPASVIRSOFOSBUVIR | 1 | Oral | 1 DF, QD | 205834 | 1 | DF | TABLET | QD | ||||||
125383352 | 12538335 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | 1000 MG, QD | 0 | 1000 | MG | QD | |||||||
125383352 | 12538335 | 3 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Unknown | 600 UNK, UNK | 0 | 600 | MG | QD | |||||||
125383352 | 12538335 | 4 | C | EPREX | ERYTHROPOIETIN | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125383352 | 12538335 | 1 | Hepatitis C |
125383352 | 12538335 | 2 | Hepatitis C |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125383352 | 12538335 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125383352 | 12538335 | Anaemia | |
125383352 | 12538335 | Asthenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125383352 | 12538335 | 1 | 20160510 | 0 | ||
125383352 | 12538335 | 2 | 20160510 | 0 |